BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33210239)

  • 1. Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in
    Zamboglou C; Bettermann AS; Gratzke C; Mix M; Ruf J; Kiefer S; Jilg CA; Benndorf M; Spohn S; Fassbender TF; Bronsert P; Chen M; Guo H; Wang F; Qiu X; Grosu AL
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1987-1997. PubMed ID: 33210239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on
    Yi Z; Hu S; Lin X; Zou Q; Zou M; Zhang Z; Xu L; Jiang N; Zhang Y
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1523-1534. PubMed ID: 34845536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Validation of PSMA Expression Measured by
    Woythal N; Arsenic R; Kempkensteffen C; Miller K; Janssen JC; Huang K; Makowski MR; Brenner W; Prasad V
    J Nucl Med; 2018 Feb; 59(2):238-243. PubMed ID: 28775203
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of
    Satapathy S; Singh H; Kumar R; Mittal BR
    AJR Am J Roentgenol; 2021 Mar; 216(3):599-607. PubMed ID: 32755196
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive significance of intraprostatic volumetric parameters derived from early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate cancer patients.
    Erdogan EB; Tekce E; Koca S; Aslan N; Toluk O; Aydin M
    Nucl Med Commun; 2024 Jul; 45(7):629-641. PubMed ID: 38835183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Impact of
    Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
    J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
    J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the value of
    Luo L; Zheng A; Chang R; Li Y; Gao J; Wang Z; Duan X
    Cancer Imaging; 2023 Nov; 23(1):108. PubMed ID: 37924154
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
    In Vivo; 2023; 37(3):1318-1322. PubMed ID: 37103095
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and histopathological validation of
    Heetman JG; Hermsen R; Exterkate L; Küsters-Vandevelde HVN; Brouwer LJM; Somford DM; van den Bergh RCN; van Basten JA
    Prostate; 2023 Oct; 83(14):1332-1341. PubMed ID: 37455399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of [
    Ghezzo S; Mapelli P; Bezzi C; Samanes Gajate AM; Brembilla G; Gotuzzo I; Russo T; Preza E; Cucchiara V; Ahmed N; Neri I; Mongardi S; Freschi M; Briganti A; De Cobelli F; Gianolli L; Scifo P; Picchio M
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2548-2560. PubMed ID: 36933074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-Head Comparison of
    Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
    J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of
    Sonni I; Eiber M; Fendler WP; Alano RM; Vangala SS; Kishan AU; Nickols N; Rettig MB; Reiter RE; Czernin J; Calais J
    J Nucl Med; 2020 Aug; 61(8):1153-1160. PubMed ID: 31924715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.